Dried prothrombin complex
Brand names: Beriplex, Octaplex
Dried prothrombin complex concentrate is a plasma-derived product containing vitamin K-dependent clotting factors, used to reverse vitamin K antagonist anticoagulation and to treat or prevent bleeding due to deficiency of these factors.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It rapidly replaces clotting factors II, VII, IX and X, restoring thrombin generation and the coagulation cascade.
Prescribing in practice
- Carries a risk of thromboembolic complications including disseminated intravascular coagulation, so it should be reserved for clear indications and given with careful clinical assessment.
- When used to reverse a vitamin K antagonist, concurrent intravenous vitamin K is usually required because the effect of the concentrate is temporary.
- Being plasma-derived, it carries a theoretical risk of transmissible infection despite manufacturing safety steps, and the brand and batch should be recorded.
Monitoring
Monitor coagulation parameters such as the INR and clinical signs of bleeding or thrombosis before and after administration.
Counselling the patient
- Tell the team about any history of clots, heart disease or previous reactions to blood products.
- Report symptoms of a clot, such as leg swelling, chest pain or breathlessness, promptly.
Evidence & guidelines
Prothrombin complex concentrate is recommended for emergency reversal of vitamin K antagonists in major bleeding by NICE and haematology guidelines.
Reference: BSH warfarin reversal guideline; NICE NG24; NICE NG143; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO